Science and technology are constantly evolving, especially the way we understand disease, develop drugs and recommend treatments. The concept of personalized medicine has emerged with growing advances in genomic and proteomic science over the past decade. Development of “targeted” diagnostics and therapeutic medicines have received a boost because of advances in personalized medicine.
According to a report by “Verified Market Research” Personalized Medicine Market was valued at US$ 96.97 Billion in 2018 and is expected to witness a growth of 10.67% from 2019 and reach US$ 217.90 Billion by 2026.
Identifying the drug best suited to the specific biology of a patient’s disease can be achieved by specific ex vivo tests, based on the functionality of a patient’s diseased cells and their reaction to potential treatment. US-based Celcuity develops cell-based assays using a cellular analysis platform. Specific cellular data of patients offer clinicians and pharmaceutical companies unique insights into a patient’s response to drug therapy, thereby, improving the reaction to the targeted medicine.
Genetic testing provides data that can be used to identify potential health risks and to gain insight into the molecular background of diseases.
Latest artificial intelligence (AI) and machine learning technologies help identify patterns within genetic data sets so that computer models can make predictions about an individual’s odds of developing a disease or responding to interventions. Austrian startup Platomics creates PlatoX — a digital infrastructure for physicians, laboratory and test providers, that ensures high analysis quality and highly scalable testing procedures of genetic diseases using Next Generation Sequencing (NGS). This information allows analyzing thousands of mutations in the human genome using modern methods of information technology and artificial intelligence.
Digital imaging provides insights to treat the abnormalities precisely. 3D printing transforms the approach to personalized care delivery. 3D printed models facilitate a better understanding of abnormalities, encourage novel surgical techniques and improve the surgical outcome for patients. Irish startup Axial3D is focused on driving the global adoption of 3D printing within healthcare. Axial3D provides precise, patient-specific 3D printed models, generated directly from a patient’s CT and MRI scan.
Variations in genetic constitution contributes to differences in appearance and health for every individual. Further innovation and sustained growth of personalized medicine will improve the future of health care and health systems.
Credits : Akhil Handa